Menu Search
Equities

Zoetis Inc

1ZTS:MIL

Zoetis Inc

Actions
  • Price (EUR)168.66
  • Today's Change0.20 / 0.12%
  • Shares traded25.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 13:53 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

  • Revenue in USD (TTM)9.15bn
  • Net income in USD2.43bn
  • Incorporated2012
  • Employees14.10k
  • Location
    Zoetis Inc10 Sylvan WayPARSIPPANY 07054United StatesUSA
  • Phone+1 (973) 822-7000
  • Fax+1 (302) 655-5049
  • Websitehttps://www.zoetis.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.